Authors: Villalona-Calero, MA Blum, JL Jones, SE Diab, S Elledge, R Khoury, P Von Hoff, D Kraynak, M Moczygemba, J Kromelis, P Griffin, T Rowinsky, EK

Citation: Ma. Villalona-calero et al., A phase I and pharmacologic study of capecitabine and paclitaxel in breastcancer patients, ANN ONCOL, 12(5), 2001, pp. 605-614

Authors: Diab, SG Baker, SD Joshi, A Burris, HA Cobb, PW Villalona-Calero, RA Eckhardt, SG Weiss, GR Rodriguez, GI Drengler, R Kraynak, M Hammond, L Finizio, M Von Hoff, DD Rowinsky, EK

Citation: Sg. Diab et al., A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors, CLIN CANC R, 5(2), 1999, pp. 299-308

Authors: Villalona-Calero, MA Petit, T Kuhn, J Cobb, P Kraynak, M Eckhardt, SG Drengler, R Simmons, C Santabarbara, P Von Hoff, DD Rowinsky, EK

Citation: Ma. Villalona-calero et al., A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignancies, CLIN CANC R, 5(11), 1999, pp. 3369-3378

Authors: Villalona-Calero, MA Weiss, GR Burris, HA Kraynak, M Rodrigues, G Drengler, RL Eckhardt, SG Reigner, B Moczygemba, J Burger, HU Griffin, T Von Hoff, DD Rowinsky, EK

Citation: Ma. Villalona-calero et al., Phase I and pharmacokinetic study of the oral fluoropyrimidine capecitabine in combination with paclitaxel in patients with advanced solid malignancies, J CL ONCOL, 17(6), 1999, pp. 1915-1925

Authors: Nemunaitis, J Holmlund, JT Kraynak, M Richards, D Bruce, J Ognoskie, N Kwoh, TJ Geary, R Dorr, A Von Hoff, D Eckhard, SG

Citation: J. Nemunaitis et al., Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer, J CL ONCOL, 17(11), 1999, pp. 3586-3595